Skip to main content
. 2004 Aug;137(2):402–407. doi: 10.1111/j.1365-2249.2004.02529.x

Table 1.

Plasma cytokine levels (pg/ml) for patient and control groups

Name ID CAT Weeks Days Th1/Th2 CBA kit Inflammatory CBA kit

IFN-γ TNF-α IL-10 IL-5 IL-4 IL-2 IL-12 TNF-α IL-10 IL-6 IL-1b IL-8
P1 57 c-staph 1 2 0 0 1·2 1·5 0 0 0 0 1·6 0 2·1 14·6
P2 58 gbs 1 3 0 1·4 1·8 2·2 1·5 1·4 21·6 11 7·1 0 89·5 57·5
P3 59 serrati 1 2 0 0 8·4 7·5 0 0 8·7 0 26 9·9 19·4 380
P4 60 s.aure 1 5 723 3·5 13·5 2·1 0 0 24·7 7·8 27·2 3080 0 861
P5 61 kleb 1 1 10·3 8·9 4313·8 1·9 0 0 12·7 13·1 4763 4270 30 529
P6 63 candid 1 3 30 0 10·9 0 0 0 31·9 1·9 33·8 66·4 36·3 122
C1 62 c 1 7 0 0 2·1 1·3 0 0 9·6 0 7·6 0 11·5 47
C2 64 c 1 5 1·7 0 2·5 1·8 1·2 0 0 0 7·8 0 16·4 73
C3 65 c 1 4 4·9 1·5 2·4 2·1 1·5 0 0 2·6 2·9 0 6·5 67
C4 66 c 1 6 2·6 0 2·3 1·6 0 0 0 1·5 3·6 0 0 26
C5 67 c 1 2 1·2 1 1·6 6·7 1·3 0 0 0 0 34·1 10·2 95
C6 68 c 1 6 1·7 1·4 1·4 1·8 1·2 0 0 0 0 0 0 54
*Mean 4·8 2·0 0·5 2·0 2·5 0·9 0 1·6 0·7 3·6 5·7 7·4 60·3
s.d. 1·79 1·65 0·73 0·45 2·05 0·70 0 3·9 1·10 3·46 13·92 6·57 23·68
Range 1–7·4 0–5·5 0–2·9 1·7–3·5 0–6·6 0–2·3 >0 0–9·6 0–2·9 0–11 0–32 0–21 13–108
P7 69 c-staph 2 8 16·4 0 3·7 19 1·1 3·3 0 0 7·2 0 13·4 80
P8 70 c-staph 2 10 2·4 1·4 4·3 18·5 0 0 0 0 6·5 182 0 360
P9 71 ecoli 2 8 1·9 0 0 3·8 0 0 20·2 0 0 0 45·7 62
P10 72 c-staph 2 10 0 1·2 497·3 1·7 0 0 0 0 425 0 29 0
P11 73 mycop 2 9 0 0 1·6 0 0 0 0 0 10·4 0 8·1 45
P12 74 candid 2 11 8·3 1·8 70·6 0 0 0 0 5·8 243 100 14·6 3594
C7 75 c 2 9 0 0 1·8 4·5 0 0 0 0 5·2 0 4·2 62
C8 86 c 3 13 6·4 0 5·9 2·8 0 0 0 0 14 23·7 7 106
C9 77 c 2 10 0 0 2 1·7 1·9 1·2 0 0 0 0 0 22
C10 89 c 2 14 5·5 0 1·4 0 2·2 0 0 0 9 22·8 0 96
C11 79 c 2 13 0 1·3 0 0 1·6 0 0 2·9 4 5·4 17 129
C12 80 c 2 9 0 0 2·6 4 1·2 1·4 0 5·8 8 0 13 61
*Mean 11·3 2·0 0·2 2·3 2·2 1·1 0·4 0 1·4 6·7 8·6 6·9 79·3
s.d. 2·25 3·08 0·53 1·97 1·94 0·95 0·70 0 2·43 4·79 11·50 6·95 38·41
Range 7–16·1 0–8 0–1·2 0–6·3 0–6 0–3 0–1·7 >0 0–6·3 0–16 0–32 0–20 2–156
P13 81 candid 3 17 0 0 2·1 0 0 0 141 0 0 16 155 97
P14 82 candid 3 16 0 0 2·6 5·1 1·7 0 0 0 9·5 0 12·1 162
P15 84 c-staph 3 15 251·7 1·9 188·1 0 0 1·1 0 4·5 325 167·3 4·2 105
P16 85 gbs 3 19 9 2·2 4·2 1·3 1·2 2·3 0 9·7 0 15 67·8 150
P17 76 unident 3 18 19 0 13·8 1·9 1·2 0 8·5 1·4 34·8 39·7 23 78
P18 78 unident 3 16 2·7 0 12·4 7 1·2 0 4·3 0 35 64·4 14·5 186
C13 83 c 3 20 3·7 0 1·9 1·7 1·1 0 0 0 0 26·5 0 142
C14 86 c 3 16 6·4 0 5·9 2·8 0 0 0 0 14 23·7 7 106
C15 87 c 3 19 0 0 0 1·1 0 0 0 3·4 5 0 13·4 38
C16 88 c 3 17 0 1·1 3·2 3·6 0 0 0 2·4 13 0 11·4 136
C17 89 c 3 15 5·5 0 1·4 0 2·2 0 0 0 9 22·8 0 96
C18 90 c 3 18 2·6 0 0 2·7 0 0 0 0 6 0 17 12
*Mean 17·5 3·0 0·2 2·1 2·0 0·6 0 0 0·9 7·8 12·1 8·1 88·3
s.d. 1·87 2·70 0·44 2·23 1·31 0·92 0 0 1·53 5·27 13·38 7·08 52·69
Range 14–21 0–8·4 0–1 0–6·4 0–3·6 0–2·4 >0 >0 0–4 0–18 0–39 0–22 0–193

Gbs, group B streptococcus: s.aureus, Staphylococcus aureus: c-staph, coagulase negative staphylococcus: ecoli, Escherichia coli: ser, Serratia marscecens: klebs, Klebsiella: mycoplas, Mycoplasma pneumoniae: unident, unidentified organisms.

*

Mean, standard deviation and range for cytokine levels for control groups aged 0–7, 8–14 and 15–21 days.

Bold type indicates significantly increased level of cytokine in infected group compared to control group. C (control), P (patient).